Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry

Karolina Badora 1 Aleksandra Caban 1 Cécile Rémuzat 2 Claude Dussart 3, 4 Mondher Toumi 5
1 Creativ-Ceutical Poland, Cracow, Poland.
2 Creativ-Ceutical, Paris , France
3 P2S - Parcours santé systémique
4 Faculté de Médecine Laennec, Université de Lyon, Lyon, France.
5 AMU MED - Aix-Marseille Université - Faculté de médecine
Abstract : In Poland, two proposed amendments to the reimbursement act are currently in preparation ; these are likely to substantially change the pricing and reimbursement landscape for both drugs and medical devices. Proposed changes include: alignment of medical device reimbursement with that of pharmaceuticals; relaxing the strict reimbursement criteria for ultra-orphan drugs; establishment of an additional funding category for vaccines; introduction of compassionate use, and a simplified reimbursement pathway for well-established off-label indications; appreciation of manufacturers' innovation and research and development efforts by creating a dedicated innovation budget; introduction of a mechanism preventing excessive parallel import; prolonged duration of reimbursement decisions and reimbursement lists; and increased flexibility in defining drug programmes. Both amendments are still at a draft stage and many aspects of the new regulations remain unclear. Nonetheless, the overall direction of some of the changes is already evident and warrants discussion due to their high expected impact on pharmaceutical and device manufacturers. Here we evaluate the main changes proposed to the reimbursement of drugs, vaccines, and medical devices, and examine the impact they are likely to have on market access and pharmaceutical industry in Poland. ARTICLE HISTORY
Keywords : medical devices drug policy Poland pharmaceuticals Pricing and reimbursement reimbursement policy
Document type :
Journal articles
Complete list of metadatas

Cited literature [32 references]  Display  Hide  Download
https://hal-univ-lyon1.archives-ouvertes.fr/hal-01722743
Contributor : Catherine Billard <>
Submitted on : Monday, March 5, 2018 - 9:30:08 AM
Last modification on : Thursday, November 21, 2019 - 2:35:59 AM
Long-term archiving on: Wednesday, June 6, 2018 - 2:00:41 PM

File

Proposed changes to the reimbu...
Publisher files allowed on an open archive

Identifiers

Collections

UNIV-LYON1 | UNIV-AMU | UDL

Citation

Karolina Badora, Aleksandra Caban, Cécile Rémuzat, Claude Dussart, Mondher Toumi. Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry. Journal of Market Access & Health Policy, Taylord & Francis, 2017, 5 (1), ⟨10.1080/20016689.2017.1381544⟩. ⟨hal-01722743⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

196

Files downloads

352

Contact

Informations

CCSD